全文获取类型
收费全文 | 2606篇 |
免费 | 118篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 164篇 |
妇产科学 | 91篇 |
基础医学 | 349篇 |
口腔科学 | 53篇 |
临床医学 | 176篇 |
内科学 | 581篇 |
皮肤病学 | 42篇 |
神经病学 | 130篇 |
特种医学 | 77篇 |
外科学 | 254篇 |
综合类 | 38篇 |
预防医学 | 217篇 |
眼科学 | 192篇 |
药学 | 187篇 |
中国医学 | 9篇 |
肿瘤学 | 153篇 |
出版年
2023年 | 8篇 |
2022年 | 42篇 |
2021年 | 74篇 |
2020年 | 38篇 |
2019年 | 57篇 |
2018年 | 64篇 |
2017年 | 46篇 |
2016年 | 66篇 |
2015年 | 66篇 |
2014年 | 84篇 |
2013年 | 114篇 |
2012年 | 202篇 |
2011年 | 219篇 |
2010年 | 143篇 |
2009年 | 101篇 |
2008年 | 158篇 |
2007年 | 155篇 |
2006年 | 132篇 |
2005年 | 141篇 |
2004年 | 147篇 |
2003年 | 111篇 |
2002年 | 125篇 |
2001年 | 39篇 |
2000年 | 39篇 |
1999年 | 31篇 |
1998年 | 24篇 |
1997年 | 15篇 |
1996年 | 21篇 |
1995年 | 7篇 |
1994年 | 9篇 |
1993年 | 13篇 |
1992年 | 14篇 |
1991年 | 20篇 |
1990年 | 21篇 |
1989年 | 13篇 |
1988年 | 14篇 |
1987年 | 9篇 |
1986年 | 11篇 |
1985年 | 16篇 |
1984年 | 8篇 |
1983年 | 5篇 |
1982年 | 8篇 |
1981年 | 7篇 |
1980年 | 9篇 |
1979年 | 9篇 |
1978年 | 8篇 |
1976年 | 7篇 |
1974年 | 9篇 |
1970年 | 5篇 |
1938年 | 9篇 |
排序方式: 共有2731条查询结果,搜索用时 15 毫秒
31.
Angiotensin converting enzyme (ACE) inhibitors and dihydropyridine calcium antagonists are well established and widely used as monotherapy in patients with mild to moderate essential hypertension. Earlier studies combining short acting drugs from these classes require multiple dosing and were associated with poor compliance. Availability of longer acting compounds allows once daily administration to avoid the inconvenience of a multiple daily dose. It was decided to perform a randomised double blind, crossover study with the long acting calcium channel blocker amlodipine and the long acting ACE inhibitor lisinopril, given either alone or in combination in essential hypertension. Twenty four patients with diastolic blood pressure (DBP) between 95 and 104 mm Hg received amlodipine 2.5 mg and 5 mg, lisinopril 5 mg and 10 mg, and their combination as per a prior randomisation schedule. Supine and standing blood pressure and heart rate were recorded at weekly intervals. Higher doses of both the drugs individually or in combination were used if the target supine DBP below 90 mm Hg was not achieved. There was a significant additional blood pressure lowering effect with the combination when compared either with amlodipine or lisinopril alone. Five mg amlodipine and 10 mg lisinopril monotherapy achieved the target blood pressure in 71% and 72% patients respectively. The combination of 2.5 mg amlodipine with 5 mg lisinopril produced a much more significant lowering of blood pressure in a higher percentage of patients than that with an individual low dose. 相似文献
32.
T. M. Ramanujam A. Sergius V. Usha S. Ramanathan 《Pediatric surgery international》1998,14(1-2):134-137
Urethral duplication (UD) is an uncommon malformation. Obstruction rarely occurs in hypospadiac UD. We describe two children
with incomplete hypospadiac UD in association with posterior urethral valves, a combination not previously recognised. The
embryonic significance of this anomaly is discussed.
Accepted: 30 September 1997 相似文献
33.
34.
G. K. Maheshwari H. A. Baboo Usha Gopal M. K. Wadhwa 《Indian journal of otolaryngology and head and neck surgery》2004,56(2):138-141
Sarcomas constitute fewer than 1% of the head and neck cancers. They represent less than 1% of laryngeal cancers. Primary
rhabdomyosarcoma of the larynx is an extremely rare malignancy. The available literature on this medical oddity is in the
form of isolated case reports only. The purpose of this article is to add another case of primary rhabdomyosarcoma of a rare
site, the larynx, of which only 36 cases have so far been reported in the world literature. The present patient, an eighteen-year-old
boy is only the third case being reported from India among all reported cases of rhabdomyosarcoma of the larynx in the world
literature. 相似文献
35.
Usha Stiefel Nicole J Pultz Marion S Helfand Curtis J Donskey 《Infection control and hospital epidemiology》2004,25(5):373-379
BACKGROUND: Antibiotic-associated disruption of the indigenous intestinal microflora may persist beyond the treatment period. Although piperacillin/tazobactam inhibits the establishment of vancomycin-resistant Enterococcus (VRE) stool colonization in mice during treatment, we hypothesized that this agent and other anti-anaerobic antibiotics would increase susceptibility to colonization during the period of recovery of the intestinal microflora. DESIGN: Mice received 10(4) colony-forming units of vancomycin-resistant E. faecium by orogastric inoculation 2, 5, or 10 days after completing 5 days of subcutaneous antibiotic treatment, or both during and 2 days after the completion of treatment. Denaturing gradient gel electrophoresis (DGGE) was performed to assess changes in the intestinal microflora. RESULTS: Anti-anaerobic antibiotics (ie, piperacillin/ tazobactam, cefoxitin, and clindamycin) caused significant disruption of the indigenous microflora (mean DGGE similarity indices < or = 27% in comparison with saline controls) and promoted the establishment of high-density colonization when VRE was inoculated 2 or 5, but not 10, days following treatment (P < .001). Piperacillin/tazobactam exhibited a biphasic effect on the establishment of colonization (ie, inhibition when exposed to VRE during treatment and promotion when exposed to VRE after discontinuation of treatment), resulting in greater overall promotion of colonization than did agents with minimal anti-anaerobic activity (ie, levofloxacin, cefepime, and aztreonam) when VRE was inoculated both during and 2 days after treatment (P < .001). CONCLUSION: Patients receiving anti-anaerobic antibiotics, including piperacillin/tazobactam, may be susceptible to the establishment of high-density VRE colonization during the period of recovery of the anaerobic microflora. 相似文献
36.
Vetriselvan Subramaniyan Shivkanya Fuloria Hari Kumar Darnal Dhanalekshmi Unnikrishnan Meenakshi Mahendran Sekar Rusli Bin Nordin Srikumar Chakravarthi Kathiresan V. Sathasivam Shah Alam Khan Yuan Seng Wu Usha Kumari Kalvatala Sudhakar Rishabha Malviya Vipin Kumar Sharma Neeraj Kumar Fuloria 《Asian Pacific journal of tropical medicine》2021,(9):401-409
In the current pandemic, COVID-19 patients with predisposing factors are at an increased risk of mucormycosis, an uncommon angioinvasive infection that is caused by fungi with Mucor genus which is mainly found in plants and soil. Mucormycosis development in COVID-19 patient is related to various factors, such as diabetes, immunocompromise and neutropenia. Excessive use of glucocorticoids for the treatment of critically ill COVID-19 patients also leads to opportunistic infections, such as pulmonary aspergillosis. COVID-19 patients with mucormycosis have a very high mortality rate. This review describes the pathogenesis and various treatment approaches for mucormycosis in COVID-19 patients, including medicinal plants, conventional therapies, adjunct and combination therapies. 相似文献
37.
38.
A basic phospholipase A2 (PLA2) enzyme, TFV PL-X (pI 9.2) and two acidic PLA2 enzymes, TFV PL-Ia (pI 4.9) and TFV PL-Ib (pI 4.5) were purified from Trimeresurus flavoviridis venom on CM-Sephadex C-25 and QAE-Sephadex A-25 columns, respectively. The basic enzyme exists as a monomer, whereas the acidic enzymes are dimers. These enzymes differ in properties such as molecular weight, Km, optimum pH and temperature and pharmacological properties. The basic enzyme hydrolysed purified phospholipids in the order of PC greater than PE greater than PS greater than PI = 0, while for TFV PL-Ia and TFV PL-Ib the order was PC greater than PE greater than PS = PI = 0. TFV PL-X was comparatively more toxic, with an LD50 value of 4.2 micrograms/g (i.p.), while the acidic PLA2 enzymes had LD50 values above 8 micrograms/g (i.p.). All three enzymes induced edema when injected into the mouse foot pad. Aristolochic acid, an alkaloid (8-methoxy-6-nitrophenanthro(3,4-d)-1,3-dioxole-5-carboxylic acid) from the medicinal plant Aristolochia radix, interacts with these PLA2 enzymes. It is a competitive inhibitor with varying affinity when PC is used as substrate. Aristolochic acid inhibits direct and indirect hemolytic activity, as well as edema-inducing activity, of TFV PL-X, but fails to neutralize the lethal potency of the enzyme. On the other hand, it inhibits direct and indirect lytic activity of TFV PL-Ia and TFV PL-Ib only at 10-fold higher concentrations and it enhances the edema-inducing activity of these enzymes. Such effects of aristolochic acid indicates that (1) different mechanisms may be involved in the edema-inducing activity of PLA2 enzymes and (2) catalytic and pharmacological sites are separate on the PLA2 molecule. 相似文献
39.
40.